Dietary Supplement
Polyglucosamine L112
Polyglucosamine L112 is a dietary supplement with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects
NCT04375696
completednot_applicable
Influence of Polyglucosamine L112 on Serum Surrogate Markers of Cholesterol Absorption
NCT05038436
completednot_applicable
Polyglucosamine L112 in Overweight and Obese Subjects
NCT05022732
Clinical Trials (3)
Showing 3 of 3 trials
NCT04375696Phase 4
Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects
NCT05038436Not Applicable
Influence of Polyglucosamine L112 on Serum Surrogate Markers of Cholesterol Absorption
NCT05022732Not Applicable
Polyglucosamine L112 in Overweight and Obese Subjects
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3